Company: GMRE
Filing Date: 2025-11-13
Form Type: 424B5
Source: 0001104659-25-110926
Chunk: 11

Company: Global Medical REIT Inc.
Filing Date: 2025-11-13
Form: 424B5
Chunk 11
---
, but excluding, the date of redemption. If, prior to the Change of Control Conversion Date (as defined below), we have provided or provide notice of our election to redeem the Series B Preferred Stock (whether pursuant to our optional redemption right or our special redemption option), the holders of Series B Preferred Stock will not be permitted to exercise the conversion right described below with respect to the shares subject to such notice. |

<div align='center'>S-3</div>

| A “Change of Control” means, after the initial issuance of the Series B Preferred Stock, the following have occurred and are continuing: |

| · | the acquisition by any person, including any syndicate or group deemed to                                                                       
 be a “person” under Section 13(d)(3) of the Exchange Act, of beneficial ownership, directly or indirectly, through                              
 a purchase, merger, conversion or other acquisition transaction or series of purchases, mergers, conversions or other acquisition transactions, 
 of shares of our stock entitling that person to exercise more than 50% of the total voting power of all outstanding shares of our stock         
 entitled to vote generally in the election of directors (except that the person will be deemed to have beneficial ownership of all securities   
 that the person has the right to acquire, whether the right is currently exercisable or is exercisable only upon the occurrence of a subsequent 
 condition); and                                                                                                                                 |

| · | following the closing of any transaction referred to in the bullet point                                                              
 above, neither we nor the acquiring or surviving entity has a class of common equity securities listed on the NYSE, the NYSE American 
 or Nasdaq, or listed or quoted on an exchange or quotation system that is a successor to the NYSE, NYSE American or Nasdaq.           |

| Notwithstanding the foregoing, if the transaction or series                                                                             
 of transactions described in the first bullet point above (the “Change of Control Transaction”) forms part of a series of               
 related transactions that are closed or consummated within twelve (12) months of the closing or consummation of the Change of Control   
 Transaction (including, without limitation, any merger, consolidation, sale or transfer of assets, recapitalization, reorganization, or 
 special or extraordinary distribution, in each case outside of the ordinary course of our business (the “Related Transactions”)),       
 and if the aggregate consideration paid to us and/or holders of our common stock in connection with the Change of Control Transaction   
 represents less than 50.0% of the aggregate consideration